Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pDONR223-ZNF624 Citations (1)

Originally described in: A comprehensive library of human transcription factors for cell fate engineering.
Ng AHM, Khoshakhlagh P, Rojo Arias JE, Pasquini G, Wang K, Swiersy A, Shipman SL, Appleton E, Kiaee K, Kohman RE, Vernet A, Dysart M, Leeper K, Saylor W, Huang JY, Graveline A, Taipale J, Hill DE, Vidal M, Melero-Martin JM, Busskamp V, Church GM Nat Biotechnol. 2021 Apr;39(4):510-519. doi: 10.1038/s41587-020-0742-6. Epub 2020 Nov 30.
PubMed Journal

Articles Citing pDONR223-ZNF624

Articles
All-trans retinoic acid inhibits HCV replication by downregulating core levels via E6AP-mediated proteasomal degradation. Lee HK, Yoon H, Jang KL. Biochem Biophys Res Commun. 2022 Feb 26;594:15-21. doi: 10.1016/j.bbrc.2022.01.052. Epub 2022 Jan 17. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.